Clinical trial
Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy…
NCT00339183 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00339183 |
|---|---|
| Title | Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy Alone |
| Official title | A Randomized, Multicenter Phase 3 Study to Compare the Efficacy of Panitumumab in Combination With Chemotherapy to the Efficacy of Chemotherapy Alone in Patients With Previously Treated Metastatic Colorectal Cancer |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Metastatic Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Panitumumab, FOLFIRI |
| Enrollment | 1,186 |
| Start date | Jun 30, 2006 |
| Primary completion | Apr 1, 2009 |
| Completion | Nov 1, 2010 |
| First posted | Jun 20, 2006 |
| Last update posted | Sep 23, 2022 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: